| Literature DB >> 29389568 |
Hui-Fang Chiu1, Su-Chun Hsiao2, Yan-Ying Lu3, Yi-Chun Han2, You-Cheng Shen4, Kamesh Venkatakrishnan2, Chin-Kun Wang2.
Abstract
Pearl is one of the well-known traditional Chinese medicine (TCM) prescribed for treating various skin and bone related disorders due to its abundant proteins and mineral contents. The present investigation focused on antioxidation and life span prolonging effects from different extracts of pearl powder. During in vitro studies, various oxidative indices were evaluated, along with lifespan-prolonging effect were checked using wild-type Caenorhabditis elegans. For the clinical trial, 20 healthy middle-aged subjects were recruited and separated into 2 groups as experimental and placebo group, who received 3 g of pearl powder/d (n = 10) and 3 g of placebo/d (n = 10) for 8 weeks, respectively. During the initial, 2nd, 4th, 6th, 8th and 10th weeks the blood samples were collected for biochemical analysis. The protein extract of pearl powder recorded maximum (p < 0.05) antioxidant activity (20-68%) as well as efficiently prolonged the life span of C. elegans by 18.87%. Pearl powder supplemented subjects showed a substantial increase (p < 0.05) in total antioxidant capacity from 0.45 to 0.69 mM, total thiols from 0.23 to 0.29 mM, Glutathione content from 5.89 to 9.19 μM, enzymic antioxidant activity (SOD-1248 to 1308; Gpx-30 to 32; GR-2.4 to 2.9) as well as considerably suppressed the lipid peroxidation products from 4.95 to 3.27 μM. The outcome of both in-vitro and in-vivo antioxidant activity inferred that protein extract of pearl powder was a potent antioxidant and thereby prolonged the lifespan of C. elegans. Hence, pearl powder could be recommended for treating various age-related degenerative disorders.Entities:
Keywords: Antioxidant; Caenorhabditis elegans; Clinical trial; Longevity; Pearl powder
Mesh:
Substances:
Year: 2017 PMID: 29389568 PMCID: PMC9332669 DOI: 10.1016/j.jfda.2017.05.010
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Fig. 1Schematic representation of the present study.
Protein contents in pearl powder.
| Contents (mg protein/g dry wt) | |
|---|---|
| Pearl powder | 22.71 ± 2.19 |
| Protein extract of pearl powder | 182.25 ± 0.11 |
Fig. 2Analysis of proteins from pearl powder by SDS-PAGE.
The total antioxidant capacity in pearl powder.
| TEAC (μmol/g dry wt.) | |
|---|---|
| Pearl Powder | 72.32 ± 3.58b |
| Protein extract of pearl powder | 587.12 ± 32.55a |
| Non-protein (fraction) of pearl powder | 26.55 ± 2.79c |
TEAC (μmol/g dry wt.): μmol trolox equivalent antioxidant capacity/per g dry wt.
Values were expressed as means ± SD. Data represented with different superscript letters were significantly different (p < 0.05).
Fig. 3The chelating ability in various pearl powder extracts. Values were expressed as means ± SD. Data represented with different letters were significantly different (p < 0.05).
Fig. 4The scavenging efficiency on DPPH (A) and Superoxide anion (B) in various pearl powder extracts. Values were expressed as means ± SD. Data represented with different letters were significantly different (p < 0.05).
Fig. 5The prolonging lifespan (longevity) effect of various concentrations of protein extract of pearl powder in C. elegans.
The effect of pearl powder on anthropometric parameters in healthy subjects.
| Group | Height (cm) | Weight (Kg) | Body Fat (%) | ||
|---|---|---|---|---|---|
| Baseline | Exp | 160.67 ± 10.66a | 65.22 ± 13.98a | 27.65 ± 7.16a | 23.43 ± 3.35a |
| Placebo | 166.10 ± 09.21a | 57.23 ± 6.83a | 24.40 ± 5.22a | 22.09 ± 1.06a | |
| 2nd week | Exp | 160.67 ± 10.66a | 65.13 ± 14.34a | 27.53 ± 6.50a | 23.38 ± 3.46a |
| Placebo | 166.10 ± 09.21a | 57.22 ± 6.65a | 24.71 ± 5.70a | 22.08 ± 1.01a | |
| 4th week | Exp | 160.67 ± 10.66a | 64.67 ± 13.76a | 28.48 ± 7.59a | 23.26 ± 3.23a |
| Placebo | 166.10 ± 09.21a | 56.79 ± 6.57a | 24.72 ± 5.20a | 21.90 ± 1.07a | |
| 6th week | Exp | 160.67 ± 10.66a | 65.23 ± 14.00a | 28.26 ± 5.72a | 23.43 ± 3.32a |
| Placebo | 166.10 ± 09.21a | 57.01 ± 6.97a | 25.06 ± 4.85a | 22.01 ± 1.21a | |
| 8th week | Exp | 160.67 ± 10.66a | 65.78 ± 14.04a | 28.42 ± 8.21a | 23.63 ± 3.35a |
| Placebo | 166.10 ± 09.21a | 57.08 ± 7.02a | 24.87 ± 5.22a | 22.02 ± 1.16a | |
| Follow Up (10th week) | Exp | 160.67 ± 10.66a | 65.29 ± 14.21a | 28.21 ± 7.87a | 23.44 ± 3.40a |
| Placebo | 166.10 ± 09.21a | 56.99 ± 6.66a | 25.36 ± 4.62a | 22.00 ± 0.90a |
Values were expressed as means ± SD. Data within the same column of each group represented by different superscript letters were significantly different (p < 0.05).
BMI: body mass index.
The effect of pearl powder on various oxidative indexes in plasma of healthy subjects.
| Group | TEAC (mM)* | TBARS (μM) | Thiols (mM) | GSH (μM) | Vit-C (mg/dL) | |
|---|---|---|---|---|---|---|
| Baseline | Exp | 0.45 ± 0.04f | 4.95 ± 0.52a | 0.23 ± 0.05a | 5.89 ± 0.82e | 2.48 ± 0.17a |
| Placebo | 0.48 ± 0.08a | 4.82 ± 0.39a | 0.27 ± 0.04a | 6.16 ± 0.76a | 2.42 ± 0.26a | |
| 2nd week | Exp | 0.52 ± 0.02e | 4.55 ± 0.41b | 0.23 ± 0.04a | 6.92 ± 0.58d | 2.48 ± 0.14a |
| Placebo | 0.47 ± 0.08a | 4.83 ± 0.37a | 0.26 ± 0.04a | 6.34 ± 0.69a | 2.42 ± 0.28a | |
| 4th week | Exp | 0.59 ± 0.04d | 4.15 ± 0.36c | 0.25 ± 0.05a | 7.67 ± 0.60c | 2.47 ± 0.13a |
| Placebo | 0.44 ± 0.06a | 4.84 ± 0.34a | 0.26 ± 0.03a | 6.22 ± 0.64a | 2.41 ± 0.27a | |
| 6th week | Exp | 0.63 ± 0.04c | 3.87 ± 0.32d | 0.26 ± 0.05a | 8.27 ± 0.53b | 2.47 ± 0.14a |
| Placebo | 0.48 ± 0.06a | 4.81 ± 0.36a | 0.26 ± 0.04a | 6.40 ± 0.55a | 2.42 ± 0.25a | |
| 8th week | Exp | 0.66 ± 0.05b | 3.51 ± 0.44e | 0.29 ± 0.05b | 9.19 ± 0.42a | 2.48 ± 0.13a |
| Placebo | 0.48 ± 0.07a | 4.84 ± 0.28a | 0.26 ± 0.03a | 5.89 ± 0.82b | 2.41 ± 0.23a | |
| Follow Up (10th week) | Exp | 0.69 ± 0.05a | 3.27 ± 0.34f | 0.29 ± 0.05b | 9.21 ± 0.66a | 2.49 ± 0.11a |
| Placebo | 0.49 ± 0.08a | 4.81 ± 0.35a | 0.25 ± 0.04a | 5.93 ± 0.59b | 2.42 ± 0.21a |
Values were expressed as means ± SD. Data within the same column of each group represented by different superscript letters were significantly different (p < 0.05).
The effect of pearl powder on the antioxidant enzymes in erythrocytes of healthy subjects.
| Group | SOD (IU/g Hb) | Gpx (IU/g Hb) | GR (IU/g Hb) | |
|---|---|---|---|---|
| Baseline | Exp | 1248.95 ± 200.54a | 30.35 ± 5.61b | 2.41 ± 0.68a |
| Placebo | 1245.65 ± 159.64a | 31.77 ± 7.11a | 2.42 ± 0.67a | |
| 8th week | Exp | 1321.75 ± 134.72b | 34.22 ± 7.68a | 3.30 ± 0.81a |
| Placebo | 1267.95 ± 109.74a | 32.03 ± 6.89a | 2.37 ± 0.90a | |
| Follow Up (10th week) | Exp | 1308.16 ± 182.04b | 32.60 ± 5.99ab | 2.91 ± 0.58a |
| Placebo | 1248.92 ± 171.93a | 31.38 ± 6.24a | 2.40 ± 0.60a |
Values were expressed as means ± SD. Data within the same column of each group represented with different superscript letters were significantly different (p < 0.05).